Abstract
Using population and epidemiologic data for 48 countries in sub-Saharan Africa, we used a model-based approach to estimate cervical cancer cases and deaths averted, disability-adjusted life years (DALYs) averted and incremental cost-effectiveness ratios (I$ (international dollar) per DALY averted) for human papillomavirus (HPV) vaccination of pre-adolescent girls. Additional epidemiologic data from Uganda and South Africa informed estimates of cancer risk reduction and cost-effectiveness ratios associated with pre-adolescent female vaccination followed by screening of women over age 30. Assuming 70% vaccination coverage, over 670,000 cervical cancer cases would be prevented among women in five consecutive birth cohorts vaccinated as young adolescents; over 90% of cases averted were projected to occur in countries eligible for GAVI Alliance support. There were large variations in health benefits across countries attributable to differential cancer rates, population size, and population age structure. More than half of DALYs averted in sub-Saharan Africa were in Nigeria, Tanzania, Uganda, the Democratic Republic of the Congo, Ethiopia, and Mozambique. When the cost per vaccinated girl was I$5 ($0.55 per dose), HPV vaccination was...Continue Reading
References
Jun 28, 2001·JAMA : the Journal of the American Medical Association·S J GoldieT C Wright
Jun 1, 2005·Sexually Transmitted Infections·G S OgilvieJ M FitzGerald
Sep 1, 2005·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Wolfgang Greiner
Jul 4, 2007·Vaccine·Sue J GoldieEduardo L Franco
Aug 7, 2007·Lancet·Rengaswamy SankaranarayananJacob Cherian
Sep 5, 2007·Bulletin of the World Health Organization·Angela Oloo AkumuUlla K Griffiths
Feb 1, 2008·Bulletin of the World Health Organization·Lara J WolfsonJean-Marie Okwo-Bele
Jun 14, 2008·Vaccine·Sue J GoldieSun-Young Kim
Jul 8, 2008·Vaccine·Jane J KimSue J Goldie
Aug 22, 2008·The New England Journal of Medicine·Jane J Kim, Sue J Goldie
Sep 23, 2008·The Lancet Oncology·You-Lin QiaoAttila T Lorincz
Nov 26, 2008·Vaccine·Sue J GoldieSun-Young Kim
Nov 1, 2008·Vaccine·Sue J GoldieJane J Kim
Apr 3, 2009·The New England Journal of Medicine·Rengaswamy SankaranarayananKetayun A Dinshaw
Oct 10, 2009·BMJ : British Medical Journal·Jane J Kim, Sue J Goldie
Apr 14, 2010·PloS One·Karen K Smith-McCuneGeorge F Sawaya
Apr 17, 2010·AIDS·Sarah H AverbachNancy S Padian
Jun 25, 2010·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Myron J LevinUNKNOWN IMPAACT P1047 Protocol Team
Jul 9, 2010·AIDS·Nienke J VeldhuijzenJanneke H van de Wijgert
Jul 20, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Mireia DiazJane J Kim
Aug 14, 2010·AIDS·Louise KuhnLynette Denny
May 26, 2011·PLoS Medicine·Mulindi H MwanahamuntuGroesbeck P Parham
Jun 18, 2011·BMC Infectious Diseases·Sun-Young KimSue J Goldie
Jul 1, 2011·International Journal of Cancer. Journal International Du Cancer·Nicole G CamposSue J Goldie
Aug 6, 2011·Vaccine·Harrell W ChessonLauri E Markowitz
Nov 15, 2011·Best Practice & Research. Clinical Obstetrics & Gynaecology·Rengaswamy SankaranarayananJean-Marie Dangou
Citations
Aug 5, 2015·Journal of Clinical Medicine·Anna-Lise Williamson
Aug 12, 2014·The Lancet Global Health·Mark JitRaymond Hutubessy
Dec 18, 2013·Vaccine·Lynette A DennyF Xavier Bosch
May 7, 2015·International Journal of Cancer. Journal International Du Cancer·Nicole G CamposJane J Kim
Jul 2, 2016·Virusdisease·Damiano PizzolKajal D Chhaganlal
Oct 7, 2016·PloS One·Nicole G CamposStephen C Resch
Dec 15, 2015·BMC Infectious Diseases·Xiao LiNadia Demarteau
Mar 16, 2017·International Journal of Cancer. Journal International Du Cancer·Alex K MezeiGina S Ogilvie
Dec 9, 2017·BMC Health Services Research·Obinna I Ekwunife, Stefan K Lhachimi
Aug 26, 2018·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·Austin M OberlinCarla J Chibwesha
Oct 3, 2017·PLoS Medicine·Alyssa BilinskiJoshua A Salomon
Nov 7, 2016·BMC Cancer·Qian ZhangFang-Hui Zhao
Jul 12, 2017·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·D Scott LaMontagneCathy Ndiaye
Apr 26, 2017·Expert Review of Anti-infective Therapy·Ralph-Sydney Mboumba BouassaLaurent Bélec
Sep 18, 2016·PharmacoEconomics·Obinna I EkwunifeStefan K Lhachimi
Aug 3, 2019·BMC Public Health·Sergi AlonsoKhátia Munguambe
Jul 28, 2020·International Journal of Public Health·Saba AbidiPuneeta Ajmera
Sep 11, 2019·Papillomavirus Research·Karen CanfellMark Jit
Jul 17, 2019·Gynecologic Oncology Reports·Ava S RungeKrishnansu S Tewari
Nov 3, 2021·BMJ Global Health·Allison PortnoyMark Jit
Nov 7, 2021·International Journal of Cancer. Journal International Du Cancer·Jennifer C SpencerJane J Kim